• Username (E-mail)
  • Password
Dow 19,800 -0.1%  EStoxx50 3,281 0.3%  Nikkei 18,788 -0.6%  EUR 1.0731 -0.3% 
Nasdaq 5,553 0.0%  FTSE100 7,172 0.3%  Yen 113.3740 0.7%  Oil 55.5 0.2% 
S&P500 2,265 -0.3%  DAX 11,575 0.3%  GBP 1.2448 -0.7%  Gold 1,212 -0.6% 

Exxon Mobil share [Symbol: XOM / ISIN: US30231G1022]

01/09/2017 10:35:33 AM
01/09/2017 10:35:33 AM UTC-0500

Exxon Mobil Corp. (ExxonMobil) Neutral

The analysts of JP Morgan Chase & Co. have rated Exxon Mobil with a Neutral rating. The price target was set to 94.00 $. At a current price of the Exxon Mobil stock of 85.00 $ this means an upside potential of 10.59%.
Summary: Exxon Mobil Corp. (ExxonMobil) Neutral
Company:
Exxon Mobil Corp. (ExxonMobil)
Analyst:
JP Morgan Chase & Co.
Price Target:
94.00 $
Current Rating:
Neutral
Price*:
86.89 $
Distance to Target Price*:
8.18%
Previous Rating:
-
Latest Price:
85.00 $
Distance Price Target:
10.59%
Analyst Name::
Phil Gresh
P/E Ratio*:
-

Analyst Opinions for Exxon Mobil Corp. (ExxonMobil)

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell
01/19/17
Exxon Mobil UBS AG
01/17/17
Exxon Mobil Jefferies & Company Inc.
01/09/17
Exxon Mobil JP Morgan Chase & Co.
12/20/16
Exxon Mobil Goldman Sachs Group Inc.
11/08/16
Exxon Mobil HSBC

Add or Edit Instrument

Related Stocks

Latest Analyst Opinions
01/23/17 TLG IMMOBILIEN Norddeutsche Landesbank (Nord/LB)
01/23/17 ABB JP Morgan Chase & Co.
01/23/17 Zurich Insurance Group JP Morgan Chase & Co.
01/23/17 Apple Bernstein Research
01/23/17 Novo Nordisk A-S (B) JP Morgan Chase & Co.
01/23/17 Sky UBS AG
01/23/17 Vodafone Group UBS AG
01/23/17 BT Group UBS AG
01/23/17 RHÖN-KLINIKUM Independent Research GmbH
01/23/17 Credit Suisse Morgan Stanley
01/23/17 Deutsche Bank Morgan Stanley
01/23/17 Intesa Sanpaolo JP Morgan Chase & Co.
01/23/17 HORNBACH Baumarkt Hauck & Aufhäuser Privatbankiers KGaA
01/23/17 RHÖN-KLINIKUM Commerzbank AG
01/23/17 NORMA Group Oddo Seydler Bank AG
01/23/17 Reckitt Benckiser Group Barclays Capital
01/23/17 Deutsche Bank Commerzbank AG
01/23/17 LOréal Barclays Capital
01/23/17 Diageo Barclays Capital
01/23/17 LVMH Moet Hennessy Louis Vuitton Deutsche Bank AG
01/23/17 Renault UBS AG
01/23/17 Continental UBS AG
01/23/17 Daimler UBS AG
01/23/17 adidas Deutsche Bank AG
01/23/17 AstraZeneca Deutsche Bank AG
01/23/17 CompuGroup Medical Baader Bank
01/23/17 Bechtle Baader Bank
01/23/17 Beiersdorf Barclays Capital
01/23/17 Henkel vz Barclays Capital
01/23/17 Unilever Barclays Capital
01/23/17 Unilever Barclays Capital
01/23/17 GlaxoSmithKline Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
01/23/17 Orange Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
01/23/17 BNP Paribas Deutsche Bank AG
01/23/17 Société Générale SA Deutsche Bank AG
01/23/17 zooplus Warburg Research
01/23/17 ASML Baader Bank
01/23/17 Novo Nordisk A-S (B) Kepler Cheuvreux
01/23/17 Vonovia Kepler Cheuvreux
01/23/17 AIXTRON Baader Bank
01/23/17 Anheuser-Busch InBev UBS AG
01/23/17 PUMA Deutsche Bank AG
01/23/17 Glencore UBS AG
01/23/17 BT Group UBS AG
01/23/17 Royal Dutch Shell (A) UBS AG
01/23/17 Eni UBS AG
01/23/17 LOréal UBS AG
01/23/17 PUMA JP Morgan Chase & Co.
01/23/17 Novo Nordisk A-S (B) Goldman Sachs Group Inc.
01/23/17 Hapag-Lloyd Aktiengesellschaft Goldman Sachs Group Inc.